Clinical Trial Update: Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

View source ↗

Summary

A Stanford University-sponsored clinical trial aims to characterize patients with recessive dystrophic epidermolysis bullosa and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Snippet

Sponsor: Stanford University | Conditions: Epidermolysis Bullosa Dystrophica | Status: RECRUITING